AU2005216697A1 - Extracts of Scutellaria for the treatment of SARS - Google Patents

Extracts of Scutellaria for the treatment of SARS Download PDF

Info

Publication number
AU2005216697A1
AU2005216697A1 AU2005216697A AU2005216697A AU2005216697A1 AU 2005216697 A1 AU2005216697 A1 AU 2005216697A1 AU 2005216697 A AU2005216697 A AU 2005216697A AU 2005216697 A AU2005216697 A AU 2005216697A AU 2005216697 A1 AU2005216697 A1 AU 2005216697A1
Authority
AU
Australia
Prior art keywords
botanical
scutellaria
medicament
spp
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005216697A
Other languages
English (en)
Inventor
Robert Miller
Hongwen Yu
Shouming Zhong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phynova Ltd
Original Assignee
Phynova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phynova Ltd filed Critical Phynova Ltd
Publication of AU2005216697A1 publication Critical patent/AU2005216697A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AU2005216697A 2004-02-27 2005-02-25 Extracts of Scutellaria for the treatment of SARS Abandoned AU2005216697A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0404327.9 2004-02-27
GB0404327A GB2411354B (en) 2004-02-27 2004-02-27 Use of Scutellaria for the treatment of viral infections
PCT/GB2005/000714 WO2005082388A1 (en) 2004-02-27 2005-02-25 Extracts of scutellaria for the treatment of sars

Publications (1)

Publication Number Publication Date
AU2005216697A1 true AU2005216697A1 (en) 2005-09-09

Family

ID=32050939

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005216697A Abandoned AU2005216697A1 (en) 2004-02-27 2005-02-25 Extracts of Scutellaria for the treatment of SARS

Country Status (7)

Country Link
US (1) US20080038382A1 (enExample)
EP (1) EP1734976A1 (enExample)
JP (1) JP2007524709A (enExample)
CN (1) CN1925863A (enExample)
AU (1) AU2005216697A1 (enExample)
GB (2) GB2411354B (enExample)
WO (1) WO2005082388A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006100710A1 (ja) * 2005-03-18 2008-08-28 太陽化学株式会社 重症急性呼吸器症候群の予防および治療用組成物
CN101701245B (zh) * 2009-10-21 2013-06-19 中国科学院生物物理研究所 从中药中筛选sars冠状病毒主蛋白酶抑制剂的方法
CN103720650A (zh) * 2014-01-17 2014-04-16 中国药科大学 一种具有抗流感病毒作用的黄芩苷注射剂
CN104800318A (zh) * 2014-01-26 2015-07-29 天津嘉创生物科技有限公司 治疗畜禽上呼吸道感染的中药组合物及其制备方法
CN105372377B (zh) * 2014-08-07 2017-09-29 富力 一种原料药连翘苷的质量检测方法
CN104356185B (zh) * 2014-09-26 2017-05-17 山西大学 一种提取黄芩苷的方法
CN105168807B (zh) * 2015-10-16 2019-04-19 大连民族大学 治疗猪蓝耳病的中药组合物及其制备方法
CN113209164B (zh) * 2020-02-06 2023-01-20 中国科学院上海药物研究所 黄芩、连翘、金银花主要成分及其组合物在抗冠状病毒中的应用
CN113244211B (zh) * 2020-02-07 2023-04-07 中国科学院上海药物研究所 黄芩素、黄芩苷用于制备冠状病毒SARS-CoV-2的3CL蛋白酶的抑制剂的用途
CN113244212B (zh) * 2020-02-10 2023-05-05 中国医学科学院药物研究所 黄芩素在制备预防和/或治疗新型冠状病毒感染疾病的药物中的应用
CN113368121A (zh) * 2020-03-09 2021-09-10 吉林亚泰制药股份有限公司 抗冠状病毒的连翘苷和连翘脂素组合物
WO2021188614A1 (en) * 2020-03-18 2021-09-23 Dejia Harmony Llc Composition, methods of making and using for treating a viral infection, including coronavirus infection
AU2021281159B2 (en) * 2020-05-29 2024-09-19 Vedicinals India Private Limited A composition for management of COVID-19 and associated disorders
RU2741714C1 (ru) * 2020-08-13 2021-01-28 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Ингибитор репликации коронавируса SARS-CoV-2 на основе водного экстракта гриба Inonotus obliquus
US20220054575A1 (en) * 2020-08-19 2022-02-24 Natreon, Inc. Protection against coronavirus infection by extracts and extract components
RU2747018C1 (ru) * 2020-10-14 2021-04-23 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере зашиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Ингибитор репликации коронавируса SARS-CoV-2 на основе меланина из гриба Inonotus obliquus
RU2752872C1 (ru) * 2020-11-03 2021-08-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Ингибитор репликации коронавируса SARS-CoV-2 на основе гуминовых веществ
CN113813271B (zh) * 2020-11-09 2023-12-12 首都医科大学 连翘酯苷f在制备抗冠状病毒产品中的应用
CN118477064B (zh) * 2024-05-14 2024-12-20 南阳师范学院 黄芩素在抗大口黑鲈弹状病毒方面的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
US6083921A (en) * 1998-01-12 2000-07-04 Xu; Kai Jian Pharmaceutical compositions and method of using same
CN1309399C (zh) * 2000-10-25 2007-04-11 国家中药制药工程技术研究中心 复方双黄连制剂及制备方法
CN1470262A (zh) * 2002-07-23 2004-01-28 北京大学安康药物研究院 一种双黄连制剂及其制备方法
CN1449813A (zh) * 2003-04-29 2003-10-22 兰金初 治疗非典型肺炎的药物
CN1159060C (zh) * 2003-05-06 2004-07-28 哈药集团中药二厂 注射用双黄连在制备用于治疗严重急性呼吸道综合症的药物中的应用
CN1454665A (zh) * 2003-06-02 2003-11-12 丁润泉 一种防治sars病毒的中药
CN1164267C (zh) * 2003-06-02 2004-09-01 中国科学院上海药物研究所 绿原酸的医学用途及它的制剂
CN1238037C (zh) * 2003-06-09 2006-01-25 方文理 治疗肺炎和非典型肺炎的药物
CN1135111C (zh) * 2003-06-13 2004-01-21 胡馨元 抗非典型性肺炎汤
CN1476886A (zh) * 2003-07-01 2004-02-25 陈淀炜 抗癌抗sars保健茶

Also Published As

Publication number Publication date
WO2005082388A1 (en) 2005-09-09
US20080038382A1 (en) 2008-02-14
CN1925863A (zh) 2007-03-07
GB0404327D0 (en) 2004-03-31
EP1734976A1 (en) 2006-12-27
GB2411354A (en) 2005-08-31
JP2007524709A (ja) 2007-08-30
GB2425476A (en) 2006-11-01
GB0608398D0 (en) 2006-06-07
GB2411354B (en) 2008-02-20

Similar Documents

Publication Publication Date Title
Yang et al. Food as medicine: A possible preventive measure against coronavirus disease (COVID‐19)
Silveira et al. COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy?
US20080038382A1 (en) Extracts of Scutellaria for the Treatment of Sars
Karimi et al. Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID‐19, a multicenter open‐labeled, randomized, controlled clinical trial
US7422760B2 (en) Plant-based medicament for the treatment of Hepatitis C
US7198804B2 (en) Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
US20080233220A1 (en) Further Medical Use Of A Botanical Drug Or Dietary Supplement
KR20130003520A (ko) 생약 제제를 포함하는 숙취 예방 또는 해소용 조성물
Jamiu et al. Phytotherapeutic evidence against coronaviruses and prospects for COVID-19
TR201802779T4 (tr) Bitkisel formülasyonlar.
Brenes et al. Genus Pelargonium: General aspects, potential pharmacological applications, extraction methods and applications in industry
WO2022250542A1 (en) System-biology based pharmaceutical composition comprising a mixture of herb extracts as active ingredients, use of said composition as a medicament, particularly in the treatment of human coronavirus infections such as covid-19
CN103432421A (zh) 一种增强免疫力的药物组合物
GB2425477A (en) Extract of Scutellaria for the treatment of RSV
JP2007126410A (ja) 肝疾患予防及び治療用生薬組成
KR102913937B1 (ko) 운금만병초(포츄네이) 추출물을 함유하는 항바이러스 조성물
CN105267291B (zh) 一种用于治疗或保护肝损伤的复方组合物
UPADHYAY HERBAL TREATMENTS FOR RESPIRATORY VIRAL DISEASES
Zafar et al. Medicinal plants as COVID-19 remedy
Silveira et al. Fonseca-Bazzo YM
Panchamoorthy et al. Natural Resources for Human Health
Gupta et al. Ethnopharmacological approaches for COVID-19 therapy
KR20250108370A (ko) 섬오갈피나무 추출물을 함유하는 근감소증의 예방 또는 치료용 조성물
Heinrich COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
CN101717692B (zh) 香叶蒿挥发油及其提取工艺和应用

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application